Coeptis Therapeutics Holdings, Inc.
COEP
$15.92
-$0.04-0.25%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.75M | -3.53M | -3.06M | -1.95M | -1.73M |
| Total Depreciation and Amortization | 305.80K | 305.50K | 305.30K | 260.00K | 278.20K |
| Total Amortization of Deferred Charges | 58.00K | 387.80K | 99.90K | 66.20K | 0.00 |
| Total Other Non-Cash Items | 1.81M | 1.21M | 507.10K | 229.50K | -305.20K |
| Change in Net Operating Assets | -579.90K | -769.20K | -220.80K | -44.30K | -138.80K |
| Cash from Operations | -2.15M | -2.40M | -2.37M | -1.44M | -1.89M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 100.00K | 0.00 |
| Cash from Investing | -- | -- | -- | 100.00K | 0.00 |
| Total Debt Issued | 0.00 | 0.00 | 990.00K | 0.00 | 0.00 |
| Total Debt Repaid | 0.00 | 0.00 | -218.80K | -63.50K | 0.00 |
| Issuance of Common Stock | 5.06M | -- | -- | 100.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -50.00K |
| Issuance of Preferred Stock | 0.00 | 125.00K | 5.33M | 695.40K | 1.53M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.00 | 100.00 | 400.00 | 0.00 | 0.00 |
| Cash from Financing | 5.06M | 125.10K | 6.10M | 732.00K | 1.48M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 0.00 | -- |
| Net Change in Cash | 2.91M | -2.27M | 3.74M | -604.60K | -417.60K |